论文信息 - Long-Term Follow up of a Phase II Study of Guadecitabine (SGI-110) in Patients with Higher-Risk Myelodysplastic Syndrome (MDS) - 字舞流文

Long-Term Follow up of a Phase II Study of Guadecitabine (SGI-110) in Patients with Higher-Risk Myelodysplastic Syndrome (MDS)

H. Kantarjian | G. Garcia-Manero | T. Kadia | F. Ravandi | Koichi Takahashi | G. Borthakur | E. Jabbour | N. Daver | C. Dinardo | S. Pierce | N. Pemmaraju | Kiyomi Morita | M. Azab | Y. Alvarado | M. Ohanian | K. Sasaki | Feng Wang | P. Bose | G. Bravo | Kristy Bodden